VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,122,340 | -37.6% | 78,861 | -30.2% | 0.01% | -33.3% |
Q2 2023 | $3,402,545 | +129176.0% | 113,004 | +39.0% | 0.01% | +12.5% |
Q1 2023 | $2,632 | +70.4% | 81,325 | +50.8% | 0.01% | +60.0% |
Q4 2022 | $1,545 | -99.9% | 53,931 | +13.4% | 0.01% | 0.0% |
Q3 2022 | $1,146,000 | +1.1% | 47,538 | +14.8% | 0.01% | 0.0% |
Q2 2022 | $1,133,000 | -39.3% | 41,399 | -14.9% | 0.01% | -28.6% |
Q1 2022 | $1,866,000 | +169.7% | 48,646 | +125.3% | 0.01% | +133.3% |
Q4 2021 | $692,000 | -5.3% | 21,595 | -13.0% | 0.00% | -25.0% |
Q3 2021 | $731,000 | +3.8% | 24,820 | +19.8% | 0.00% | 0.0% |
Q2 2021 | $704,000 | +11.9% | 20,715 | +7.0% | 0.00% | 0.0% |
Q1 2021 | $629,000 | -14.7% | 19,364 | -5.4% | 0.00% | -33.3% |
Q4 2020 | $737,000 | +13.0% | 20,464 | +23.0% | 0.01% | 0.0% |
Q3 2020 | $652,000 | -94.9% | 16,641 | -96.6% | 0.01% | -99.0% |
Q3 2016 | $12,752,000 | +63.5% | 482,488 | +71.4% | 0.62% | +46.0% |
Q2 2016 | $7,801,000 | – | 281,524 | – | 0.42% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |